-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on Nanobiotix, Raises Price Target to $46

Benzinga·06/04/2026 12:51:45
Listen to the news
Leerink Partners analyst Jonathan Chang maintains Nanobiotix (NASDAQ:NBTX) with a Outperform and raises the price target from $37 to $46.